Welcome to our dedicated page for Lifeway Food SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifeway Foods Inc. filings document the regulatory record for an Illinois operating company whose common stock trades on the Nasdaq Global Market under the symbol LWAY. Its Form 8-K reports cover operating results, sales estimates, Regulation FD disclosures, material agreements, director appointments and resignations, and compensatory arrangements under the company's 2022 Omnibus Incentive Plan.
Proxy materials describe annual shareholder meeting matters, board and committee governance, executive compensation and equity-plan administration. The filing record also identifies the company's registered securities, including common stock and preferred stock purchase rights, and includes formal disclosures related to financial reporting, governance changes and capital-structure matters.
Lifeway Foods, Inc. reported estimated unaudited net sales of $39.1 million for the first two months of its third quarter, through August 31, 2025. This represents a 20% increase compared with the same period a year earlier, indicating strong sales momentum early in the quarter.
The figures are preliminary and unaudited and were shared via a press release furnished under Regulation FD, meaning they are provided for informational purposes and are not incorporated into other securities law filings unless specifically referenced. The company also reminds readers that these sales figures and related discussion involve forward‑looking statements that are subject to various business and market risks.
Lifeway Foods reported stronger top-line and profitability in the quarter ended June 30, 2025. Net sales for the three months were $53.9 million, up 9.7% year-over-year, producing gross profit of $15.4 million (28.6% of sales) and net income of $4.249 million, or $0.28 per diluted share. For the six months, net sales were $99.99 million, net income $7.789 million, and diluted EPS $0.51.
Liquidity and balance sheet items strengthened: cash and equivalents were $21.22 million, total assets $98.27 million, and stockholders' equity $78.70 million. The company recognized a $3.407 million gain and $5.206 million proceeds from the sale of its Simple Mills investment in the six months. Lifeway increased its revolving credit commitment to $25.0 million (no borrowings outstanding) and was in compliance with covenants. In July 2025 the company purchased 224 mature dairy cows for $694 and entered a 39-month herd management agreement; accounting treatment is under evaluation.
Lifeway Foods, Inc. disclosed that it issued a press release reporting its financial results for the three and six months ended June 30, 2025, and attached that release as Exhibit 99.1 to this Form 8-K.
The company also announced estimated net sales of $26.4 million for the third quarter through August 11, 2025, which the filing states represents a 20% increase from approximately $22 million for the same period last year. The filing clarifies that the press release information is incorporated by reference and is not "filed" for Section 18 liabilities.
Danone S.A. and subsidiary Danone North America PBC filed Amendment No. 9 to their Schedule 13D on Lifeway Foods (LWAY) dated 1 Aug 2025. The group continues to own 3,454,756 common shares—22.7 % of the 15.2 million shares outstanding—held directly by the U.S. unit, giving it sole voting and dispositive power; the French parent is an indirect owner.
After Lifeway rejected two takeover proposals in 2024, the issuer reopened dialogue in late June 2025. On 1 Aug 2025 both parties executed a confidentiality agreement (NDA) to allow further due-diligence on a potential acquisition. The NDA places a stand-still that bars Danone from public bids, proxy solicitations or director nominations until 15 Sep 2025, extendable by seven days if good-faith talks continue. Danone may still vote its shares. If no definitive deal is reached by the stand-still expiry, Danone presently intends to back Edward Smolyansky’s consent solicitation to replace the entire Lifeway board.
The filing stresses that no transaction is guaranteed and Danone may change its intentions.
Edward and Ludmila Smolyansky, owners of approximately 26% of Lifeway Foods (NASDAQ: LWAY), have filed a definitive Consent Statement (July 2 2025) to remove the current board and seat seven new directors. The pair say early shareholder outreach shows growing support.
- Governance dispute: The activists accuse the board of delaying the 2025 AGM, refusing to set a record date and adopting a poison pill after dismissing Danone’s unsolicited $27 per-share offer as inadequate.
- Director sell-off: Lead independent director Jason Scher sold 24,566 shares (~$600k at $24.23), leaving only one share and apparently breaching Lifeway’s 200% retainer stock-holding policy.
- Call to action: Shareholders are urged to sign WHITE consent cards; the full solicitation materials are available on the SEC website.
Schedule 13D/A (Amendment No. 24) – Lifeway Foods, Inc. (NASDAQ: LWAY)
The filing updates the ownership positions and intentions of the Smolyansky family and related trust. Three reporting persons disclose the following beneficial holdings, calculated against 15,203,241 outstanding shares as of 6 May 2025:
- Edward Smolyansky: 3,159,975 shares (20.8%) – sole voting power over 2,584,975 and shared voting power over 575,000.
- Ludmila Smolyansky: 940,166 shares (6.2%) – sole voting power over 865,166 and shared over 75,000.
- The Edward Smolyansky Trust 2/2/16: 1,233,333 shares (8.1%) – sole voting and dispositive power.
In aggregate, the group controls approximately 35.1 % of the reported outstanding shares.
Purpose of Transaction: On 2 July 2025 the filing persons launched a consent solicitation seeking to:
- Repeal any by-law amendments adopted after 24 Mar 2023.
- Remove current directors appointed on or after 15 Jun 2024.
- Elect seven nominees (including Edward and Ludmila Smolyansky) to the board.
- Amend the by-laws to bar employment of the CEO’s immediate family members.
They simultaneously issued a press release (Ex. 99.1) and, on 7 July 2025, demanded that Lifeway call its 2025 Annual Meeting “as promptly as practicable.”
Implications: The filing signals an activist campaign aimed at overhauling governance, replacing directors and restricting nepotistic practices. With a combined stake above one-third of shares outstanding, the group wields significant influence that could reshape Lifeway’s board composition and corporate strategy.